Johnson & Johnson Selects ArisGlobal as its Global Pharmacovigilance and Safety Partner

ArisGlobal, the leading provider of pharmacovigilance and safety
systems to the life science industry, today announced its strategic
partnership with Johnson & Johnson (NYSE:JNJ). Johnson & Johnson will
deploy the ArisGlobal Total Safety suite of products on a global basis
to replace its in-house systems.

Johnson & Johnson's goal was to select a partner who could supply
a single, harmonized platform to provide global, state of the art
safety case management, signal detection and surveillance
capabilities. In addition, Johnson & Johnson needed a partner with a
shared vision and strategy to evolve and develop systems to meet the
current and future demands of a global organization such as Johnson &
Johnson.

Johnson & Johnson selected ArisGlobal as its partner because
ArisGlobal provides the most comprehensive safety solutions on the
market today, but more importantly, shares Johnson & Johnson's vision
and strategy on the future of drug safety.

"We chose ArisGlobal because they understand our business
environment and demonstrated excellent commitment during our business
and technology requirements sessions. The services and functionality
provided with ARISg combined with our development partnership with
ArisGlobal to enhance ARISg will support our requirements," said
William Truhe, Vice President of Informatics, Benefit Risk Management
at Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
"With ArisGlobal's ARISg robust feature set, flexible data model
,intuitive user interface and ability to integrate with our key
systems, Johnson & Johnson will incorporate this solution into our
existing enterprise-wide processes, knowing that they have the ability
to perform enhancements at an efficient pace.".

"The fact that Johnson & Johnson has entrusted ArisGlobal to
support their most critical business needs is extremely satisfying. It
is widely known that Johnson & Johnson has been at the forefront of
drug safety initiatives and our partnership with them will allow us to
develop a solid pharmacovigilance and risk management platform to
satisfy the demands of government, the regulators and the consumer,"
said Simon Sparkes, Vice President, Global Sales and Marketing at
ArisGlobal.

About ArisGlobal, L.L.C.

ArisGlobal, L.L.C. is a leading provider of Pharmacovigilance and
Safety, Registration Information Management, Clinical Trials
Management and Medical Communications software solutions to the Life
Sciences industry. ArisGlobal's software solutions are being used by
over 130 life science companies around the world. ArisGlobal software
helps companies meet international regulatory requirements, manage
risk, improve operational efficiencies and easily share
mission-critical information on a global basis.

About Johnson & Johnson Pharmaceutical Research & Development,
L.L.C.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.,
is part of Johnson & Johnson, the world's most broadly based producer
of health care products. Johnson & Johnson Pharmaceutical Research &
Development, L.L.C., is headquartered in Raritan, New Jersey (USA),
and has facilities throughout Europe and the United States. Johnson &
Johnson Pharmaceutical Research & Development, L.L.C., is leveraging
drug discovery and drug development in a variety of therapeutic areas
to address unmet medical needs worldwide.